Difference between revisions of "CH Basel Balavenkatraman KK"
From Bioblast
m (moved CH Basel Chiesi M to CH Basel Balavenkatraman KK) |
|||
| Line 1: | Line 1: | ||
{{MiPNetLab | {{MiPNetLab | ||
|address= | |address=Balavenkatraman Kamal Kumar, Dr. | ||
Investigator II (iTox-PCS) | |||
Novartis Pharma Ltd. | Novartis Pharma Ltd. | ||
WKL- | WKL-135.3.21 | ||
Klybeckstr 191 | |||
CH- | CH-4057 Basel, Switzerland | ||
|city=Basel | |city=Basel | ||
|country=Switzerland | |country=Switzerland | ||
|MiPNetLab= | |MiPNetLab=Balavenkatraman KK, Grueninger S, Weiss A | ||
|Team previous=Chiesi M | |||
|info=IOC39 | |info=IOC39 | ||
|Info=[http://www.oroboros.at/index.php?id=1215 CH_Basel_ChiesiM] | |Info=[http://www.oroboros.at/index.php?id=1215 CH_Basel_ChiesiM] | ||
}} | }} | ||
* Previously CH_Basel_Chiesi M | |||
Revision as of 13:26, 6 February 2012
- Previously CH_Basel_Chiesi M
